| For: | Li H, Li X, Liao XX, Zhan H, Xiong Y, Hu CL, Wei HY, Jing XL. Drug associated vanishing bile duct syndrome combined with hemophagocytic lymphohistiocytosis. World J Gastrointest Endosc 2012; 4(8): 376-378 [PMID: 22912913 DOI: 10.4253/wjge.v4.i8.376] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v4/i8/376.htm |
| Number | Citing Articles |
| 1 |
Jason J. Yang, Donald K. Lei, Vignesh Ravi, Nolan J. Maloney, Ashley Crew, Scott Worswick. Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a review. International Journal of Dermatology 2021; 60(8) doi: 10.1111/ijd.15196
|
| 2 |
Daniel Sedhom, Amanda Herrmann, Melroy DʼSouza, Billie Fyfe, Francisco Zaldana, Naomi Schlesinger, Vinod Rustgi. Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis. ACG Case Reports Journal 2018; 5(12) doi: 10.14309/02075970-201805120-00011
|
| 3 |
Paul Wasuwanich, Hassan Choudry, Joshua M. So, Sarah Lowry, Wikrom Karnsakul. Vanishing bile duct syndrome after drug-induced liver injury. Clinics and Research in Hepatology and Gastroenterology 2022; 46(9) doi: 10.1016/j.clinre.2022.102015
|
| 4 |
Hiroyuki Kato, Tsuyoshi Kitaura, Syotaro Ishihara, Ryota Amitani, Kyosuke Nagamizu, Kensaku Okada, Masaki Nakamoto, Hiroki Chikumi. Severe drug eruption induced by teicoplanin, complicated by hemophagocytic syndrome: A case report and brief literature review. Journal of Infection and Chemotherapy 2025; 31(8) doi: 10.1016/j.jiac.2025.102763
|
| 5 |
Daniel Sedhom, Amanda Herrmann, Melroy DʼSouza, Billie Fyfe, Francisco Zaldana, Naomi Schlesinger, Vinod Rustgi. Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic Sclerosis. ACG Case Reports Journal 2018; 5(1) doi: 10.14309/02075970-201805000-00095
|
| 6 |
Konstantinos Z. Vardakas, Georgios D. Kalimeris, Nikolaos A. Triarides, Matthew E. Falagas. An update on adverse drug reactions related to β-lactam antibiotics. Expert Opinion on Drug Safety 2018; 17(5) doi: 10.1080/14740338.2018.1462334
|
| 7 |
Soraya Salas-Silva, Arturo Simoni-Nieves, Jocelyn Lopez-Ramirez, Leticia Bucio, Luis E. Gómez-Quiroz, María Concepción Gutiérrez-Ruiz, Marcelo G. Roma. Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies. Life Sciences 2019; 218 doi: 10.1016/j.lfs.2018.12.044
|
| 8 |
Fernando Bessone, Nelia Hernández, Mario Tanno, Marcelo G. Roma. Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics. Seminars in Liver Disease 2021; 41(03) doi: 10.1055/s-0041-1729972
|
| 9 |
Kanika Garg, Jason Kramer, Sheila Eswaran. Common Gastrointestinal Medications Implicated in Drug‐Induced Liver Injury. Clinical Liver Disease 2021; 18(4) doi: 10.1002/cld.1110
|
| 10 |
Yang Dai, Luocheng Zhang, Xushu Zhong, Ailin Zhao, Ting Niu. Case Report: Hemophagocytic lymphohistiocytosis masquerading as drug-induced liver injury: successful treatment with low-dose ruxolitinib and glucocorticoids. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1856139
|
| 11 |
Jianglin Wang, Shengfeng Wang, Cuifang Wu, Zhenzhen Deng. Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis. Infection 2024; 52(3) doi: 10.1007/s15010-023-02132-6
|
| 12 |
Angela Shogbon Nwaesei, Pamela M. Moye-Dickerson, Robin Henry Dretler. Efavirenz-Induced Vanishing Bile Duct Syndrome: A Case Report. Journal of Pharmacy Practice 2021; 34(2) doi: 10.1177/0897190019868358
|
| 13 |
Kai Rou Tey, Kristen Barrett, Richa Jain, Thomas D. Boyer, Archita Desai. Vanishing Bile Duct Syndrome with Hemophagocytic Lymphohistiocytosis After Minimal Change Disease. The American Journal of Medicine 2016; 129(12) doi: 10.1016/j.amjmed.2016.05.029
|